Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2013

Open Access 01-12-2013 | Research article

Predictive factors of adrenal insufficiency in patients admitted to acute medical wards: a case control study

Authors: Jean-Baptiste Oboni, Pedro Marques-Vidal, François Pralong, Gérard Waeber

Published in: BMC Endocrine Disorders | Issue 1/2013

Login to get access

Abstract

Background

Adrenal insufficiency is a rare and potentially lethal disease if untreated. Several clinical signs and biological markers are associated with glucocorticoid failure but the importance of these factors for diagnosing adrenal insufficiency is not known. In this study, we aimed to assess the prevalence of and the factors associated with adrenal insufficiency among patients admitted to an acute internal medicine ward.

Methods

Retrospective, case-control study including all patients with high-dose (250 μg) ACTH-stimulation tests for suspected adrenal insufficiency performed between 2008 and 2010 in an acute internal medicine ward (n = 281). Cortisol values <550 nmol/l upon ACTH-stimulation test were considered diagnostic for adrenal insufficiency. Area under the ROC curve (AROC), sensitivity, specificity, negative and positive predictive values for adrenal insufficiency were assessed for thirteen symptoms, signs and biological variables.

Results

32 patients (11.4%) presented adrenal insufficiency; the others served as controls. Among all clinical and biological parameters studied, history of glucocorticoid withdrawal was the only independent factor significantly associated with patients with adrenal insufficiency (Odds Ratio: 6.71, 95% CI: 3.08 –14.62). Using a logistic regression, a model with four significant and independent variable was obtained, regrouping history of glucocorticoid withdrawal (OR 7.38, 95% CI [3.18 ; 17.11], p-value <0.001), nausea (OR 3.37, 95% CI [1.03 ; 11.00], p-value 0.044), eosinophilia (OR 17.6, 95% CI [1.02; 302.3], p-value 0.048) and hyperkalemia (OR 2.41, 95% CI [0.87; 6.69], p-value 0.092). The AROC (95% CI) was 0.75 (0.70; 0.80) for this model, with 6.3 (0.8 – 20.8) for sensitivity and 99.2 (97.1 – 99.9) for specificity.

Conclusions

11.4% of patients with suspected adrenal insufficient admitted to acute medical ward actually do present with adrenal insufficiency, defined by an abnormal response to high-dose (250 μg) ACTH-stimulation test. A history of glucocorticoid withdrawal was the strongest factor predicting the potential adrenal failure. The combination of a history of glucocorticoid withdrawal, nausea, eosinophilia and hyperkaliemia might be of interest to suspect adrenal insufficiency.
Appendix
Available only for authorised users
Literature
1.
go back to reference Arlt W, Allolio B: Adrenal insufficiency. Lancet. 2003, 361 (9372): 1881-1893. 10.1016/S0140-6736(03)13492-7.CrossRefPubMed Arlt W, Allolio B: Adrenal insufficiency. Lancet. 2003, 361 (9372): 1881-1893. 10.1016/S0140-6736(03)13492-7.CrossRefPubMed
4.
go back to reference Neary N, Nieman L: Adrenal insufficiency: etiology, diagnosis and treatment. Curr Opin Endocrinol Diabetes Obes. 2010, 17 (3): 217-223. 10.1097/MED.0b013e328338f608.CrossRefPubMedPubMedCentral Neary N, Nieman L: Adrenal insufficiency: etiology, diagnosis and treatment. Curr Opin Endocrinol Diabetes Obes. 2010, 17 (3): 217-223. 10.1097/MED.0b013e328338f608.CrossRefPubMedPubMedCentral
5.
go back to reference Dorin RI, Qualls CR, Crapo LM: Diagnosis of adrenal insufficiency. Ann Intern Med. 2003, 139 (3): 194-204.CrossRefPubMed Dorin RI, Qualls CR, Crapo LM: Diagnosis of adrenal insufficiency. Ann Intern Med. 2003, 139 (3): 194-204.CrossRefPubMed
6.
go back to reference Kappeler H, Schwyzer R: Synthetic peptides related to the corticotropins (ACTH) and the melanophore stimulating hormones (MSH) possessing corticotropin releasing activity (CRF-activity). Experientia. 1960, 16: 415-417. 10.1007/BF02178842.CrossRefPubMed Kappeler H, Schwyzer R: Synthetic peptides related to the corticotropins (ACTH) and the melanophore stimulating hormones (MSH) possessing corticotropin releasing activity (CRF-activity). Experientia. 1960, 16: 415-417. 10.1007/BF02178842.CrossRefPubMed
7.
go back to reference Wood JB, Frankland AW, James VH, Landon J: A Rapid Test of Adrenocortical Function. Lancet. 1965, 1 (7379): 243-245.CrossRefPubMed Wood JB, Frankland AW, James VH, Landon J: A Rapid Test of Adrenocortical Function. Lancet. 1965, 1 (7379): 243-245.CrossRefPubMed
8.
go back to reference Crowley S, Hindmarsh PC, Holownia P, Honour JW, Brook CG: The use of low doses of ACTH in the investigation of adrenal function in man. J Endocrinol. 1991, 130 (3): 475-479. 10.1677/joe.0.1300475.CrossRefPubMed Crowley S, Hindmarsh PC, Holownia P, Honour JW, Brook CG: The use of low doses of ACTH in the investigation of adrenal function in man. J Endocrinol. 1991, 130 (3): 475-479. 10.1677/joe.0.1300475.CrossRefPubMed
9.
go back to reference Rasmuson S, Olsson T, Hagg E: A low dose ACTH test to assess the function of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol. 1996, 44 (2): 151-156. 10.1046/j.1365-2265.1996.600482.x.CrossRef Rasmuson S, Olsson T, Hagg E: A low dose ACTH test to assess the function of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol. 1996, 44 (2): 151-156. 10.1046/j.1365-2265.1996.600482.x.CrossRef
10.
go back to reference Thorn GW, Goetz FC, Streeten DH, Dingman JF, Arons WL: Use of the intravenous ACTH test in clinical practice. J Clin Endocrinol Metabol. 1953, 13 (5): 604-613. 10.1210/jcem-13-5-604.CrossRef Thorn GW, Goetz FC, Streeten DH, Dingman JF, Arons WL: Use of the intravenous ACTH test in clinical practice. J Clin Endocrinol Metabol. 1953, 13 (5): 604-613. 10.1210/jcem-13-5-604.CrossRef
11.
go back to reference Lindholm J, Kehlet H, Blichert-Toft M, Dinesen B, Riishede J: Reliability of the 30-minute ACTH test in assessing hypothalamic-pituitary-adrenal function. J Clin Endocrinol Metabol. 1978, 47 (2): 272-274. 10.1210/jcem-47-2-272.CrossRef Lindholm J, Kehlet H, Blichert-Toft M, Dinesen B, Riishede J: Reliability of the 30-minute ACTH test in assessing hypothalamic-pituitary-adrenal function. J Clin Endocrinol Metabol. 1978, 47 (2): 272-274. 10.1210/jcem-47-2-272.CrossRef
12.
go back to reference Lindholm J, Kehlet H: Re-evaluation of the clinical value of the 30 min ACTH test in assessing the hypothalamic-pituitary-adrenocortical function. Clin Endocrinol. 1987, 26 (1): 53-59. 10.1111/j.1365-2265.1987.tb03638.x.CrossRef Lindholm J, Kehlet H: Re-evaluation of the clinical value of the 30 min ACTH test in assessing the hypothalamic-pituitary-adrenocortical function. Clin Endocrinol. 1987, 26 (1): 53-59. 10.1111/j.1365-2265.1987.tb03638.x.CrossRef
13.
go back to reference Clark PM, Neylon I, Raggatt PR, Sheppard MC, Stewart PM: Defining the normal cortisol response to the short Synacthen test: implications for the investigation of hypothalamic-pituitary disorders. Clin Endocrinol. 1998, 49 (3): 287-292. 10.1046/j.1365-2265.1998.00555.x.CrossRef Clark PM, Neylon I, Raggatt PR, Sheppard MC, Stewart PM: Defining the normal cortisol response to the short Synacthen test: implications for the investigation of hypothalamic-pituitary disorders. Clin Endocrinol. 1998, 49 (3): 287-292. 10.1046/j.1365-2265.1998.00555.x.CrossRef
14.
go back to reference Patel SR, Selby C, Jeffcoate WJ: The short Synacthen test in acute hospital admissions. Clin Endocrinol. 1991, 35 (3): 259-261. 10.1111/j.1365-2265.1991.tb03532.x.CrossRef Patel SR, Selby C, Jeffcoate WJ: The short Synacthen test in acute hospital admissions. Clin Endocrinol. 1991, 35 (3): 259-261. 10.1111/j.1365-2265.1991.tb03532.x.CrossRef
15.
go back to reference Cunningham SK, Moore A, McKenna TJ: Normal cortisol response to corticotrophin in patients with secondary adrenal failure. Arch Intern Med. 1983, 143: 2276-2279. 10.1001/archinte.1983.00350120066016.CrossRefPubMed Cunningham SK, Moore A, McKenna TJ: Normal cortisol response to corticotrophin in patients with secondary adrenal failure. Arch Intern Med. 1983, 143: 2276-2279. 10.1001/archinte.1983.00350120066016.CrossRefPubMed
16.
go back to reference Oelkers W: The role of high- and low-dose corticotrophin tests in the diagnosis of secondary adrenal insufficiency. Eur J Endocrinol. 1998, 139: 567-570. 10.1530/eje.0.1390567.CrossRefPubMed Oelkers W: The role of high- and low-dose corticotrophin tests in the diagnosis of secondary adrenal insufficiency. Eur J Endocrinol. 1998, 139: 567-570. 10.1530/eje.0.1390567.CrossRefPubMed
17.
go back to reference Murphy RJ, Livesey J, Espiner EA, Donald RA: The low dose ACTH test: a further word of caution. J Clin Endocrinol Metabol. 1998, 83: 712-713. 10.1210/jc.83.2.712.CrossRef Murphy RJ, Livesey J, Espiner EA, Donald RA: The low dose ACTH test: a further word of caution. J Clin Endocrinol Metabol. 1998, 83: 712-713. 10.1210/jc.83.2.712.CrossRef
Metadata
Title
Predictive factors of adrenal insufficiency in patients admitted to acute medical wards: a case control study
Authors
Jean-Baptiste Oboni
Pedro Marques-Vidal
François Pralong
Gérard Waeber
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2013
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/1472-6823-13-3

Other articles of this Issue 1/2013

BMC Endocrine Disorders 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine